Well, the last item of the "Waiting game" list can now be checked off. BETonMACE ClinicalTrials.gov is now updated to "Active, not recruiting." Actual enrollment 2425 patients. The estimated primary completion date and estimated study completion date are both now listed as June 2019. I didn't notice any other changes at first glance.

https://clinicaltrials.gov/ct2/show/NCT02586155

I am unsure how to interpret that June 2019 date. My guess is that in all current correspondence (MD&A, conference presentations, new releases, trial listings, analyst reports) that Resverlogix is using/communicating H1 2019 (by June 2019) as a conservative/generic estimate for all anticipated trial timeline events. End of dosing may still come any day now; however, as discussed previously the adjudication and follow up process will take some time.

The next 6 months are sure to be interesting!

BearDownAZ